Skip to content

Harmony Biosciences Holdings, Inc. HRMY Other intangible assets—net

Other intangible assets—net at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$534.87M-22.4%
XER
Xeris Biopharma Holdings, Inc.XERS
$85.37M-11.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6.11M-90.9%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Alkermes logo
AlkermesALKS
Axsome Therapeutics logo
Axsome TherapeuticsAXSM

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B+7.9%
Enterprise value$1.55B+2.1%
P/E13.6×+1.6×
P/S2.2×-0.3×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s other intangible assets—net?
Harmony Biosciences Holdings, Inc. (HRMY) reported other intangible assets—net of $83.46M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s other intangible assets—net changed year-over-year?
Harmony Biosciences Holdings, Inc.'s other intangible assets—net decreased by 22.2% year-over-year, from $107.3M to $83.46M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s other intangible assets—net?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s other intangible assets—net has grown at a -11.2% compound annual growth rate (CAGR), from $162.34M to $89.42M.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.